baber/WOPTO huggingface dataset:
Patent PT-2456791-E (PT)
Title: Aqueous self-crosslinkable polymer dispersion made from hard-core, soft-shell structured polymer particles, and coating or treatment compositions
Inventor: BETREMIEUX ISABELLE
IPC: C08F2/24
Filed: 2010-07-15
Abstract: The present invention relates to an aqueous polymer dispersion, which includes hard/soft Shell structured particles, with the polymer phase of the core P1 having a glass transition temperature Tg1 from 60 to 120° C., the polymer phase of the shell P2 having a glass transition temperature Tg2 from −20 to 40° C., the minimum film-formation temperature MFFT being from 0 to 50° C., with the phase P1 representing from 1.5 to 60% by weight, with respect to the total weight of P1+P2, the phase P1 including at least one monomer M1 having at least two copolymerizable ethylenic unsaturations and at least one ethylenically unsaturated monomer M2 having at least one carboxylic acid and/or anhydride functional group, the phase P2 being from 40 to 85% by weight of the total weight of P1+P2 and with said phase P2 including: at least one monomer M3 selected from the monomers having, in addition to the polymerizable ethylenic unsaturation, at least one group selected from acetoacetoxy, diacetone, methylol or alkoxysilane. The invention also relates to protective and/or decorative coating compositions such as paints, varnishes, transparent coatings, inks or adhesives and fiber treatment compositions.”
Patent PT-644768-E (PT)
Inventor: LANGUINO LUCIA R
IPC: C07K14/75
Filed: 1993-06-11
Abstract: The present invention contemplates therapeutic compositions containing a fibrinogen homolog capable of binding to endothelial cells in an RGD-independent manner that inhibits fibrinogen binding to endothelial cells. Also described are therapeutic compositions containing an ICAM-1 homolog capable of binding to fibrinogen in an RGD-independent manner that inhibits fibrinogen binding to endothelial cells. Methods of inhibiting endothelial cell and fibrinogen mediated inflammation within a patient by administering a homolog of this invention are also contemplated.
Patent PT-671923-E (PT)
Inventor: NAUGHTON BRIAN A
IPC: A61K35/407
Filed: 1993-10-08
Abstract: The present invention relates to liver reserve or progenitor cells. In particular, it relates to the isolation, characterization, culturing, and uses of liver reserve cells. Liver reserve cells isolated by density gradient centrifugation can be distinguished from other liver parenchymal cells by their morphology, staining characteristics, high proliferative activity and ability to differentiate in vitro. In long-term cultures described herein, these cells expand in numbers and differentiate into morphologically mature liver parenchymal cells, capable of mediating liver-specific functions. Therefore, isolated liver reserve cells may have a wide range of applications, including, but not limited to, their uses as vehicles of exogenous genes in gene therapy, and/or to replace and reconstitute a destroyed, infected, or genetically deficient mammalian liver by transplantation.
Patent PT-665743-E (PT)
Inventor: MINCHEV SHARMA R
IPC: A61K9/127
Filed: 1993-10-13
Abstract: This invention relates to interdigitation-fusion (IF) liposomes and gels. These liposomes and gels capture high solute to lipid ratios, including bioactive agent. This invention also relates to the discovery that the fusion of liposomes to produce IF gel and liposomes according to the present invention is size dependent. The present invention also relates to a method for producing IF liposomes and gels. In the method of the present invention, sized liposomes formed by sonication, extrusion or alternative processes are fused in the presence of ethanol or other suitable inducer. This process results in a composition of the present invention in gel form. To produce liposomes, the gels are exposed to a temperature usually but not necessarily above the transition temperature (Tm) of the lipid used. The temperature required by the methods of the invention is that temperature which induces a change in the material properties of the mixture. The inducer may also be removed. The result is a composition comprising liposomes containing high solute to lipid ratios. The IF liposomes and gels of the present invention may be used in combination with numerous solutes, especially including bioactive agents.
Patent PT-690660-E (PT)
Inventor: AUSSUDRE CHRISTIAN
IPC: H05B3/60
Filed: 1995-06-29
Abstract: The liq. is circulated through an elongated enclosure (3) having identical electrodes (4,5) at its inlet (6) and outlet (7). An AC voltage of e.g. 5 kV is generated (8) and applied between two perforated discs (15) in which the number and size of the holes depends upon the viscosity and rate of flow. At its centre the enclosure is constricted to a narrow tube (9) whose cross section is calculated for the desired rate of flow and duration of passage. <IMAGE>
Patent PT-778894-E (PT)
IPC: C07K14/155
Filed: 1995-08-28
Abstract: The invention comprises the nucleotide sequences comprising the FIPV S gene, or a fragment of this gene, which are modified in at least one of the antigenic regions A1 and A2 which are involved in enhancement, as well as the use of these sequences for the expression of modified proteins, and for the construction of recombinant viruses or expression plasmids, and the use of the recombinant viruses as vaccines against feline infectious peritonitis, the use of the expression plasmids as immunizing composition by direct injection of the said plasmids into cats, and the use of the modified proteins as vaccine.
Patent PT-839091-E (PT)
Inventor: WILLIAMS DAVID GODFREY
IPC: H05K3/12
Filed: 1996-07-18
Abstract: A support and tensioning frame for a stencil to enable solder paste to be applied to printed circuit boards and other electronic substrates includes a support frame engaged with at least two opposed mounting members. Each mounting member includes at least one projection for engaging an aperture in a stencil to mount the stencil under tension. A permanent-biasing mechanism engages one or more of the mounting members to place the stencil under tension. A second biasing mechanism engages the mounting member to provide a bias opposite that of the permanent-biasing mechanism to facilitate release of a mounted stencil.
Patent PT-821060-E (PT)
Inventor: HEINZ HOEFLER
IPC: G01N33/574
Filed: 1997-07-23
Abstract: The present invention describes monoclonal antibodies which are useful for the specific detection of diffuse gastric carcinoma. Further embodiments describe therapeutic and diagnostic means for the detection and for the therapy of diffuse gastric carcinomas.
Patent PT-892467-E (PT)
Inventor: DHANIK YOGENDRA S
IPC: H04Q1/02
Filed: 1994-01-12
Abstract: An RJ type telephone connector spring block for forming an environmentally sealed RJ type telephone socket, said spring block comprising:     a spring block body; a plurality of RJ type telephone socket contacts mounted to said spring block body; a plurality of wires electrically coupled to said RJ type telephone socket contacts; and a quantity of gel encapsulating said spring block body and at least a major portion of said RJ type telephone contacts adjacent said spring block body, wherein said encapsulated spring block is operably insertable into an RJ type telephone socket housing so as to form an environmentally sealed RJ type telephone socket.   <IMAGE>
Patent PT-1107940-E (PT)
Inventor: BOEHM MARCUS F
IPC: C07D303/23
Filed: 1999-08-12
Abstract: The present invention relates to non-secosteroidal compounds which activate and modulate the vitamin D receptor (VDR). Because compounds of the present invention display many of the beneficial properties of 1,25(OH)2D3, but with reduced calcium mobilization effects, they may be used advantageously to treat and prevent conditions that show vitamin D sensitivity. Such disease states typically show abnormal calcium regulatory, abnormal immune responsive, hyperproliferative, and/or neurodegenerative characteristics.
Patent PT-1112002-E (PT)
Inventor: LEUBA JEAN-LOUIS
IPC: A23K1/18
Filed: 1999-09-07
Abstract: A pet milk powder which, when reconstituted and fed to a pet as a nutritional milk, results in reduced gastrointestinal intolerance. This powder is a cow's milk powder that contains lactose and to which is added a lactase, preferably one that is active under acidic conditions, such as a beta-galactosidase.
Patent SG-59291-G (SG)
Title: Device for inserting at least one insert in printed products
IPC: B65H5/30
Filed: 1991-07-25
Abstract: A displacement device is arranged at an input section of a stuffing apparatus for stuffing at least one insert into folded printed products. The displacement device mutually displaces relative to one another two main printed products which have been infed in superposed or mutually reposing relationship upon one another in a predeterminate product conveying direction before these two main printed products are engaged by a transport device and further delivered to an infeed section of the stuffing apparatus. For this purpose, one printed product is fixedly retained by a clamping element controlled by a cam whereas the other printed product is displaced by a displacement or slide element in the product conveying direction. The displacement or slide element is actuated by a drive arrangement comprising an entrainment lever upon which acts a stop or abutment of the transport device during its return motion. The drive arrangement converts the return movement of the transport device into a displacement motion of the displacement or slide element in the product conveying direction.
Patent SG-63990-G (SG)
Title: Computer-controlled cordless telephone
IPC: H04W52/02
Filed: 1990-08-01
Abstract: A computer-controlled cordless telephone system having a base unit and a handset unit provides for increased functionality in communications between the base unit and the handset unit, and also provides a controlled power-up/power-down mode of operation for the handset unit. Increased functionality is achieved by employing a message format for control signals transmitted between the base unit and the handset unit in the form of frequency shift keyed (FSK) signals which include a data field. This data field may be in the form of either opcode data or digit data, thereby allowing for many different commands or functions. Power to a computer, a receiver and certain other selected circuitry in the handset unit is controlled to minimize power consumption when the handset unit is in an out-of-cradle-and-standby state. Power to other nonessential circuitry in the handset unit is turned completely off during this state. The handset unit automatically turns on to a full operating mode from the alternating power-up/power-down mode in response to events such as (1) a user depressing a key no the keypad of the handset unit for either initiating a telephone calls or paging the base unit, and (2) the base unit detecting an incoming ringing signal on the telephone lines.
Patent SG-79794-G (SG)
Title: Selective removal of hydrogen sulfide over a zinc oxide and diatomite absorbing composition.
Inventor: KIDD DENNIS RAYMOND
IPC: B01J20/10
Filed: 1994-06-20
Abstract: Hydrogen sulfide is removed from a fluid stream containing hydrogen sulfide by contacting the fluid stream under suitable absorbing conditions with an absorbing composition consisting essentially of zinc oxide and silica. Additionally, the absorbing composition may contain binders and may be promoted, preferably with nickel oxide.
Patent IE-34959-L (IE)
Title: Sewing machine presser foot assembly
IPC: D05B27/04
Filed: 1971-02-19
Abstract: 1341919 Presser foot MEFINA SA 19 April 1971 [6 March 1970] 21758/71 Heading D1G A presser foot assembly has a main support 12 fastenable to the presser bar and a sole 16 connected to the main support by intermediate means which permit the sole to move forward or backward with the work as it is fed and has means 38 actuable by the needle bar to recentre the sole when the force on the sole by the feed dog 3 is released. The intermediate means comprise a parallelogram linkage 18, 19, 20a, 21 of which link 20a supports a member 32 presenting a notch defining cam edges 35, 36 engageable with a roller 42 on the lever 38 pivoted to support 12 at 37 and having a slot 44 engaging the needle bar clamp 5. A further roller 40 on the lever 38 is engagable with a cam surface 31 on a finger 19. When the needle is at its highest position roller 40 abuts edge 31 to press the sole against the work so that the sole moves with the fed work. As the needle and feed dog descend roller 40 passes off edge 31 and roller 42 enters the notch to cooperate with cam edge 35 or 36, according to the particular direction the sole had been moved by the fed work, to recentre the sole. A paw 14 extending from support 12 has a side opening for the thread.
[GB1341919A]
Patent IE-860207-L (IE)
Title: Two jaw chuck
IPC: B23B31/107
Filed: 1986-01-24
Abstract: A tool holder of the two-jaw type is provided which has the centering accuracy and gripping power of a three-jaw geared chuck. The tool holder includes a body having ways formed by a polygonal passageway which is perpendicular to the central axis of the tool holder body. The jaw mechanism includes a differential screw which mates, on one end, with the body of the tool holder and, on the other end, with a pair of anvil pieces. The face of the differential screw and the anvil pieces move toward and away from the central axis of the tool holder along the ways formed by the polygonal passageway and provide the tool-gripping means.
[US4611960A]
Patent IE-890267-L (IE)
Title: An alka-polyene tricarboxylic acid and ester derivatives¹thereof
IPC: A61P31/04
Filed: 1989-01-27
Abstract: Isobongkrekic acid, a compound of the formula <IMAGE> with fungicidal antibiotic activity, is obtained using the Eubacterium strain Y-84,0700 (DSM 4305).
[EP0326922A2]
Patent IE-840320-L (IE)
Title: Triazole antifungal agents.
IPC: C07C45/00
Filed: 1984-02-13
Abstract: Compounds of the formula: <CHEM> where R is phenyl optionally substituted by 1 to 3 substituents each independently selected from F, Cl, Br, I, trifluoromethyl, C1-C4 alkyl and C1-C4 alkoxy, or R is a 5-chloropyrid-2-yl group; and R<1> is H, Cl, phenyl optionally substituted by 1 to 3 substituents each independently selected from F, Cl, Br, I and trifluoromethyl or a heterocyclic group linked by a carbon atom, and their O-esters, O-ethers and salts are useful in the treatment of fungal infections in humans and animals and as agricultural fungicides.
[EP0117100A1]
Patent IE-32670-L (IE)
Title: p-AMINOALKYL-BENZENESULFONAMIDE DERIVATIVES
IPC: C07D203/24
Filed: 1969-03-13
Abstract: 1,269,081. Hypoglycaemic compositions. J. R. GEIGY A.G. 14 March, 1969 [14 March, 1968], No. 13512/69. Heading A5B. [Also in Division C2] Pharmaceutical preparations showing hypoglycaemic action contain as active ingredient compounds I (including salts thereof) wherein R 1 is C 1 to 12 alkyl, C 3 to 5 alkenyl, optionally alkyl-substituted, cycloalkyl or cycloalkenyl of not more than 7 carbons or phenylalkyl of not more than 9 carbons, R 2 is H, Me or Et, R 3 is H, C 1 to 7 alkyl, C 1 to 7 chloroalkyl, alkenyl with not more than 5 carbons, optionally alkyl-substituted, cycloalkyl or cycloalkenyl or cycloalkyl-alkyl of not more than 8 carbons, phenyl phenylalkyl or phenylalkenyl of not more than 10 carbons wherein the phenyl group can be mono-, di- or tri-substituted by F, Cl, Br, CF 3 , C 1 to 4 alkyl, OH, MeO, EtO, MeS and/or EtS, R 4 is H or Me and m is 2 or 3. In addition to the usual acids, the salt forming component may be a sulphonyl - urea, e.g. N 1 - p - tolylsulphonyl - N 2 - butyl - carbamide, N 1 - p -chlorobenzenesulphonyl - N 2 - propyl - carbamide and N 1 - p - [2 - (2 - methoxy - 5 - chlorobenzamido) - ethyl] - phenylsulphonyl - N 2 - cyclohexyl - carbamide. Administration is preferably by the oral route.
[GB1269081A]
Patent IE-780694-L (IE)
Title: Collecting blood samples
IPC: A61B5/15
Filed: 1978-04-10
Abstract: A blood collection assembly for taking a blood sample from a blood source. The assembly includes a double ended hollow cannula open at both ends and mounted in a hub. A hollow evacuated blood collection tube is provided having an opening at one end. A stopper is mounted in the open end of the tube to seal the tube and maintain the vacuum therein. The hub includes a gripping surface for facilitating the holding and directing both ends of the cannula, one end into communication with the blood source and the other end into communication with the evacuated collection tube. The cannula is coupled with the stoppered tube in position for insertion of the other end thereof into communication with the interior of the stoppered tube after the one end has been connected to the blood source to permit blood to flow through the cannula into the tube for collection.
[US4155350A]
Patent IE-880719-L (IE)
Title: Acetylenes.
IPC: C07D213/80
Filed: 1988-03-11
Abstract: Retinoid-like activity is exhibited by compounds of the formula <CHEM> where R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-5; and B is H, -COOH or an ester or amide thereof, -CH2OH or an ester or ester derivative thereof, or -CHO or an acetal derivative thereof, or -COR1 or a ketal derivative thereof where R1 is -(CH2)mCH3 where m is 0-4; or a pharmaceutically acceptable salt thereof.
Patent IE-40966-L (IE)
Title: Sealing device
IPC: D02G1/12
Filed: 1975-04-07
Abstract: The invention provides an improved end-face sealing device between rotating pairs of rolls and stationary chambers of an apparatus by means of sealing elements fitted in the end-faces of the rolls and sealing plates fitted in the side walls of the chambers in such a manner that they are pressed on the said sealing elements, the sealing elements being adjustably mounted on stationary parts of said apparatus without use of bearing elements. The device is especially suitable for sealing off against solids containing liquids to be squeezed off.
[US4019788A]
Patent IE-820931-L (IE)
Title: Male urinary drainage device
IPC: A61G9/00
Filed: 1982-04-20
Abstract: A male urinary drainage device composed of a thin resilient external catheter or sheath and an adhesive sealant pad for holding the sheath in place and for producing an effective seal to prevent urine backup and leakage. The pad is formed of compressible, deformable, water-resistant, and elastic sealant material and includes a ring portion adapted to seal about the penis at or directly behind the glans thereof and at least one integral strap portion projecting radially from the ring portion and intended to extend along the penile shaft. The strap portion functions primarily to provide sheath retention, whereas the ring portion coacts with the retained sheath and with the penis to serve primarily as a barrier against fluid backup.
[US4378018A]
Patent FI-810459-L (FI)
Inventor: HOFSTADT CARL-ERNST
IPC: B01J23/80
Filed: 1981-02-13
Abstract: A process for the production of olefins from synthesis gas comprises a first synthesis stage in which a mixture of methanol and higher alcohols are formed from a synthesis gas comprising hydrogen and carbon monoxide. The catalyst for the first synthesis stage comprises the oxides of copper and zinc in intimate association with each other and a promoting compound selected from the group consisting of chromium, cerium, lanthanum, manganese, thorium, and an alkali metal. The materials from the first synthesis stage are separated into a gas phase and a liquid phase. Thereafter the methanol is separated from the higher alcohol fractions. The higher alcohols are then subjected to dehydration in a dehydration stage which comprises passing the higher alcohol fraction over an alkalized dehydration catalyst at a pressure in the range of 0.5-1 bar and a temperature in the range of 350 DEG -500 DEG  C. Thereafter the olefins produced by the dehydration of the higher alcohols are separated into the olefinic and non-olefinic materials. Preferred dehydration catalysts include alkalized aluminum oxide and alkalized calcium phosphate.
Patent IE-791031-L (IE)
Title: Tamperproof package
IPC: B65D51/18
Filed: 1979-08-08
Abstract: An improved tamperproof container for lyophilized material wherein the container comprises a vial having flange about its opening. Below the flange, but spaced apart therefrom is a shoulder to define an indented neck therebetween. The opening is sealed with a pierceable stopper. An overcap extends over the flange and about the neck to form a skirt about the neck. The skirt has at least a portion thereof extending inwardly in gripping relation with the neck and limited in removal by contact with the underside of the flange whereby the cap cannot be removed without destroying its structural integrity.
[US4211333A]
Patent IE-851084-L (IE)
Title: Kit for use in the treatment of osteoporosis
IPC: A61K31/195
Filed: 1985-04-29
Abstract: Kits for use in a regimen for treatment or prevention of osteoporosis, where the regimen comprises sequential admin. of a bone-cell-activating cpd. (I), a bone-resorption-inhibiting polyphosphonate (II) and a placebo or nutrient supplement (III), comprises the following components arranged so as to facilitate compliance with the regimen: (a) 1-5 daily doses of (I); (b) 10-20 daily doses of (II), each being 0.25-3.3 times the lowest effective dose (LED); (c) 30-100 daily doses of (III).
Patent IE-35686-L (IE)
Title: Purification of lactams
IPC: C07D201/16
Filed: 1971-09-30
Abstract: 1318459 Purifying lactams INVENTA AG 29 Sept 1971 [1 Oct 1970] 45406/71 Heading C2C A process for purifying a (C 6 -C 12 ) lactam comprises treating the lactam in the crystalline state with a (C 5 -C 12 ) aliphatic or cycloaliphatic hydrocarbon. The process is preferably carried out at a temperature of from 10‹ to 45‹ C., for 5 to 60 minutes using a weight ratio of lactam to extracting agent of at most 1 : 1. The hydrocarbon is suitably a (C 5 or C 6 ) unsubstituted cycloalkane or a (C 1 -C 10 ) alkyl derivative thereof, a (C 5 -C 10 ) straight or branched chain aliphatic hydrocarbon, or petroleum ether. Examples describe the purification of caprolactam and laurolactam.
[GB1318459A]
Patent IE-801319-L (IE)
Title: Call recording
IPC: H04M15/26
Filed: 1980-06-25
Abstract: Exchange operator's positions have a keyboard and VDU at which call details are entered by key operations or automatically from monitors, and its own program-controlled processor and buffer store. The operator's positions are connected via data links to common control equipment with suitable interface circuitry at both ends of the data links. The control equipment has its own program-controlled processor and data recording equipment. In use the control equipment, under control of its processor, polls the operators' positions in "multi-drop" manner and polling stops for the call details to be sent to and recorded by the recording equipment. If a polled position has no message to send it replies with a "no- call" message. The absence of a message from a polled operator's position is interpreted as a fault condition.
[GB2052212A]